Clinical Trials

The surgeons at Retina and Macula Specialists are regularly involved in multi-centre research trials. The outcomes of these trials benefit eye patients across the world.

  • VELODROME

    A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration

    Study WR42221 is a Phase IIIb, global, multicenter, randomized, visual assessor-masked study designed to assess the efficacy, safety, and pharmacokinetics of the Port Delivery System with ranibizumab (PDS) 100 mg/mL delivered every 36 weeks (Q36W) compared with every 24 weeks (Q24W) in patients with neovascular age-related macular degeneration (nAMD).

    Principal Investigator
    Professor Adrian Fung

    LEARN MORE
    1. Velodrome

Have a question?   Call one of our clinics today.

© 2019-2024 Eye Specialists Centre | Privacy Policy | Disclaimer | Website design: WebInjection